Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal MelanomaC. Mignard, P. Joly, M.‐T. Leccia et al.|Journal of Oncology|2018Cited by 82
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohortM. Kandel, Isabelle Borget, Stéphane Dalle et al.|European Journal of Cancer|2018Cited by 38
Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohortPauline Tétu, Célèste Lebbé, J.‐P. Lacour et al.|European Journal of Cancer|2019Cited by 35
Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data☆Y. Di Filippo, Henri Montaudié, Stéphane Dalle et al.|Annals of Oncology|2020Cited by 30
Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort StudySandra Huynh, Julie Delyon, Laurent Mortier et al.|Cancers|2020Cited by 21